Check out market updates

Brickell Biotech to sell additional $15M worth of stock as critical clinical trial begins

BOULDER — Brickell Biotech Inc. (Nasdaq: BBI) is planning to raise an additional $15 million via new stocks and warrants […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *